Current Alzheimer Research logo Bentham Science Publishers logo

Current Alzheimer Research publishes peer-reviewed frontier review and research articles on all areas of Alzheimer's disease. This multidisciplinary journal will help in understanding the neurobiology, genetics, pathogenesis, and treatment strategies of Alzheimer's disease. The journal publishes objective reviews written by experts and leaders actively engaged in research using cellular, molecular, and animal models. The journal also covers original articles on recent research in fast emerging areas of molecular diagnostics, brain imaging, drug development and discovery, and clinical aspects of Alzheimer's disease. Manuscripts are encouraged that relate to the synergistic mechanism of Alzheimer's disease with other dementia and neurodegenerative disorders. Book reviews, meeting reports and letters-to-the-editor are also published. The journal is essential reading for researchers, educators and physicians with interest in age-related dementia and Alzheimer's disease. Current Alzheimer Research provides a comprehensive 'bird's-eye view' of the current state of Alzheimer's research for neuroscientists, clinicians, health science planners, granting, caregivers and families of this devastating disease.

Publisher: Bentham Science Publishers

Volume 4, Number 5, December 2007
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Articles

Editorial [ Drug Discovery for Alzheimer's Disease: Filling the Pipeline Guest Editors: Antony R. Horton and Howard M. Fillit ]
pp. 501-502(2)
Authors: Horton, Antony R.; Fillit, Howard M.

Small Molecule Neurotrophin Receptor Ligands: Novel Strategies for Targeting Alzheimer's Disease Mechanisms
pp. 503-506(4)
Authors: Longo, Frank M.; Yang, Tao; Knowles, Juliet K.; Xie, Youmei; Moore, Laura A.; Massa, Stephen M.

NAP, A Neuroprotective Drug Candidate in Clinical Trials, Stimulates Microtubule Assembly in the Living Cell
pp. 507-509(3)
Authors: Gozes, Illana; Divinski, Inna

Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
pp. 510-517(8)
Authors: Wang, Jun M.; Irwin, Ronald W.; Liu, Lifei; Chen, Shuhua; Brinton, Roberta D.i.a.z.

Oligomers of β-Amyloid Peptide Inhibit BDNF-Induced Arc Expression in Cultured Cortical Neurons
pp. 518-521(4)
Authors: Echeverria, Valentine; Berman, Diego E.; Arancio, Ottavio

Novel Multifunctional Anti-Alzheimer Drugs with Various CNS Neurotransmitter Targets and Neuroprotective Moieties
pp. 522-536(15)
Authors: Van der Schyf, Cornelis J.; Mandel, Silvia; Geldenhuys, Werner J.; Amit, Tamar; Avramovich, Yael; Zheng, Hailin; Fridkin, Mati; Gal, Shunit; Weinreb, Orly; Am, Orit B.; Sagi, Yotam; Youdim, Moussa B.H.

Detrimental Effects of Apolipoprotein E4: Potential Therapeutic Targets in Alzheimer's Disease
pp. 537-540(4)
Authors: Mahley, Robert W.; Huang, Yadong; Weisgraber, Karl H.

APP-Based Neuroprotective Strategies
pp. 541-543(3)
Authors: Bredesen, Dale E.; Rabizadeh, Shahrooz

Inhibition of Tau Aggregation in Cell Models of Tauopathy
pp. 544-546(3)
Authors: Khlistunova, Inna; Pickhardt, Marcus; Biernat, Jacek; Wang, Yipeng; Mandelkow, Eva-Maria; Mandelkow, Eckhard

New Approaches to the Discovery of cdk5 Inhibitors
pp. 547-549(3)
Authors: Glicksman, Marcie A.; Cuny, Gregory D.; Liu, Min; Dobson, Brittany; Auerbach, Kenneth; Stein, Ross L.; Kosik, Kenneth S.

Perispinal Etanercept for Treatment of Alzheimer's Disease
pp. 550-552(3)
Author: Tobinick, Edward

Memory Improvement with Docosahexaenoic Acid Study (MIDAS)-Brief Review
pp. 553-555(3)
Author: Yurko-Mauro, Karin

Is Alpha-Synuclein Pathology a Target for Treatment of Neurodegenerative Disorders?
pp. 556-561(6)
Authors: Windisch, Manfred; Wolf, Hans-Jorg; Hutter-Paier, Birgit; Wronski, Robert

Discovery of ADDL-Targeting Small Molecule Drugs for Alzheimer's Disease
pp. 562-567(6)
Authors: Look, Gary C.; Jerecic, Jasna; Cherbavaz, Diana B.; Pray, Todd R.; Breach, Jean-Claude R.; Crosier, Walter J.; Igoudin, Lev; Hironaka, Catherine M.; Lowe, Raymond M.; McEntee, Michele; Ruslim-Litrus, Lily; Wu, Hsiu-Mei; Zhang, Sue; Catalano, Susan M.; Goure, William F.; Summa, David; Krafft, Grant A.

Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimer's Transgenic Mice
pp. 568-570(3)
Authors: Park, James H.; Strittmatter, Stephen M.

γ-Secretase Modulators
pp. 571-573(3)
Author: Wolfe, Michael S.

A New Model for Academics Based Drug Discovery
pp. 574-576(3)
Author: Stein, Ross L.

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer's Disease -an Update
pp. 577-580(4)
Author: Fisher, Abraham

Cytotoxicity of Aβ 1-42, RAGE23-54, and An Aβ -RAGE Complex in PC-12 Cells
pp. 581-586(6)
Authors: Mruthinti, Shyamala; Capito, Nicholas; Sood, Ajay; Buccafusco, Jerry J.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A